CAS Number 232925-18-7 Formula C21H25BrN3O9P Molar mass 574.3185 g/mol ChemSpider ID 4945015 | PubChem CID 6440764 3D model (Jmol) Interactive image Pubchem 6440764 | |
 | ||
Thymectacin (NB-1011, NB-101, N-[[5-[(E)-2-Bromovinyl]-2'-deoxyuridin-5'-O-yl]](phenoxy)phosphoryl]-L-alanine methyl ester) is an anticancer prodrug of brivudine monophosphate. It developed by New Biotics and it has entered in phase I clinical trials for colon cancer.
References
Thymectacin Wikipedia(Text) CC BY-SA